| 摘要 |
FIELD: medicine, pharmaceutics.SUBSTANCE: group of inventions relates to multi-component immunogenic compositions, containing a separated polypeptide of an agglutinating factor A (ClfA) of Staphylococcus aureus, a conjugate - a capsule polysaccharide of a type 5 (CP5)-protein, a conjugate - a capsule polysaccharide of a type 8 (CP8)-protein, a buffer, which has pKa 6.0±0.6, and a volume-forming agent.EFFECT: claimed compositions are characterised by an increased antigen stability.27 cl, 151 dwg, 66 tbl, 24 ex |
